#Biomarker

Circular Genomics Secures $15 Million Series A for Alzheimer's Blood Test

Cyted Health Raises €37.5M Series B for Oesophageal Cancer Diagnostics

Cyted Health secured €37.5 million in Series B financing. EQT Life Sciences, Advent Life Sciences, and British Business Bank led the round. This funding will accelerate the company's US expansion for its oesophageal cancer diagnostics.

NiaHealth Secures $5.75 Million Seed Round for Proactive Health Platform

Longevity-as-a-Service: NiaHealth bringing Canadians PROACTIVE healthcare platform, integrated with biomarker testing, fitness wearable data, and personalized clinical consultations.

AI and Spatial Biology Startup Nucleai Secured $14 Million Led by M Ventures

Ibex Medical Analytics Secures $55 Million Series C Funding for AI Cancer Diagnostics

AI-based urine analysis displays real-time health on Apple Watch

Olive WatchOS app connects to its AI-based real-time urine analysis device that mounts to any toilet. The IoT device can detect biomarkers when a person urinates normally in the toilet and alerts for the risks of conditions including dehydration and Urine Tract Infections. Clinical trials have already validated the accuracy measuring concentrations of molecules Albumin, RBC, Nitrite, pH, specific gravity and volume that are relevant to heart failure, kidney stones, renal failure, and other conditions.